Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.29
-0.14 (-2.18%)
At close: Apr 28, 2026, 4:00 PM EDT
6.24
-0.05 (-0.79%)
After-hours: Apr 28, 2026, 6:31 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $38.92 million as of April 28, 2026. Its market cap has increased by 59.54% in one year.
Market Cap
38.92M
Enterprise Value
-32.81M
1-Year Change
59.54%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $38.92M, a decrease of -92.97%. That is a compound annual growth rate of -38.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 43.10M |
| Lite Strategy | 42.91M |
| Sensei Biotherapeutics | 42.61M |
| Atara Biotherapeutics | 40.97M |
| Actinium Pharmaceuticals | 39.91M |
| Werewolf Therapeutics | 39.51M |
| RenovoRx | 38.59M |
| NextCure | 37.46M |